Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy.

作者: Tobias Klatte , Evanguelos Xylinas , Malte Rieken , Morgan Rouprêt , Harun Fajkovic

DOI: 10.1016/J.UROLONC.2013.11.010

关键词:

摘要: Objective: ABO blood type is an inherited characteristic that has been associated with the prognosis of several malignancies, but there little evidence in urothelial carcinoma bladder (UCB). The purpose this study was to evaluate effect on mortality patients UCB treated radical cystectomy (RC). Methods: Multi-institutional data from 7,906 RC between 1979 and 2012 were retrospectively analyzed. UCB-related evaluated univariable multivariable competing-risks regression models. Results: O 3,728 (47%), A 2,748 (35%), B 888 (11%), AB 532 (7%) patients. Blood a greater likelihood lymphovascular invasion (P ¼ 0.010) positive soft tissue margins 0.008). median follow-up 41 months. 5-year cumulative rates for O, A, B, 29.5%, 30.5%, 33.2%, 25.8%, respectively. In regression, had worse than those 0.026) 0.020). analysis, however, lost its statistical significance. Conclusions: Among RC, statistically significant clinically insignificant difference mortality. This association not present analysis. Our therefore suggest no relevant

参考文章(28)
Shahrokh F. Shariat, Robert S. Svatek, Derya Tilki, Eila Skinner, Pierre I. Karakiewicz, Umberto Capitanio, Patrick J. Bastian, Bjoern G. Volkmer, Wassim Kassouf, Giacomo Novara, Hans-Martin Fritsche, Jonathan I. Izawa, Vincenzo Ficarra, Seth P. Lerner, Arthur I. Sagalowsky, Mark P. Schoenberg, Ashish M. Kamat, Colin P. Dinney, Yair Lotan, Michael J. Marberger, Yves Fradet, International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy BJUI. ,vol. 105, pp. 1402- 1412 ,(2010) , 10.1111/J.1464-410X.2010.09217.X
Michela de Martino, Matthias Waldert, Andrea Haitel, Georg Schatzl, Shahrokh F. Shariat, Tobias Klatte, Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC). BJUI. ,vol. 113, ,(2014) , 10.1111/BJU.12436
Massimo Costantini, Tiziana Fassio, Luciano Canobbio, Marco Landucci, Massimo Resasco, Francesco Boccardo, Role of blood groups as prognostic factors in primary breast cancer. Oncology. ,vol. 47, pp. 308- 312 ,(1990) , 10.1159/000226839
Matthias May, Patrick J. Bastian, Sabine Brookman-May, Hans-Martin Fritsche, Derya Tilki, Wolfgang Otto, Christian Bolenz, Christian Gilfrich, Lutz Trojan, Edwin Herrmann, Rudolf Moritz, Arne Tiemann, Stefan C. Müller, Jörg Ellinger, Alexander Buchner, Christian G. Stief, Wolf F. Wieland, Thomas Höfner, Markus Hohenfellner, Axel Haferkamp, Jan Roigas, Mario Zacharias, Philipp Nuhn, Maximilian Burger, Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a Urologic Oncology: Seminars and Original Investigations. ,vol. 31, pp. 1141- 1147 ,(2013) , 10.1016/J.UROLONC.2011.09.011
James A. Vafier, Nasser Javadpour, G.F. Worsham, Kevin J. O'Connell, Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer Urology. ,vol. 23, pp. 348- 351 ,(1984) , 10.1016/0090-4295(84)90137-7
Adrian S. Fairey, Wassim Kassouf, Armen G. Aprikian, Joe L. Chin, Jonathon I. Izawa, Yves Fradet, Louis Lacombe, Ricardo A. Rendon, David Bell, Ilias Cagiannos, Darrel E. Drachenberg, Jean-Baptiste Lattouf, Eric P. Estey, Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: Results from the Canadian Bladder Cancer Network Database Urologic Oncology: Seminars and Original Investigations. ,vol. 30, pp. 825- 832 ,(2012) , 10.1016/J.UROLONC.2011.07.014
Hee-Kyung Joh, Eunyoung Cho, Toni K. Choueiri, ABO blood group and risk of renal cell cancer Cancer Epidemiology. ,vol. 36, pp. 528- 532 ,(2012) , 10.1016/J.CANEP.2012.07.001
Irene Orlow, Louis Lacombe, Inmaculada Pellicer, Farhang Rabbani, Ruby Delgado, Zuo-Feng Zhang, Irene Szijan, Carlos Cordón-Cardó, Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors International Journal of Cancer. ,vol. 75, pp. 819- 824 ,(1998) , 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y
Margaret A. Gates, Mousheng Xu, Wendy Y. Chen, Peter Kraft, Susan E. Hankinson, Brian M. Wolpin, ABO blood group and breast cancer incidence and survival International Journal of Cancer. ,vol. 130, pp. 2129- 2137 ,(2012) , 10.1002/IJC.26220